Dr. Stephanie Cardarella, MD

Dr. Cardarella practices at South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System.

Dr. Cardarella's NPI, 1295834406, was assigned on September 22, 2006. Dr. Cardarella graduated from McGill University, Faculty of Medicine in 2004. Dr. Cardarella holds Massachusetts license 230295.

Dr. Cardarella's primary practice is South Shore Hospital, at 55 Fogg Road, South Weymouth, MA 02190 in Norfolk County. The practice phone is (781) 340-8000.

Dr. Cardarella's primary practice is South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System. Dr. Cardarella is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Coastal Medical Associates. Dmand AI also links Dr. Cardarella to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cardarella practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Cardarella's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Cardarella's licenses on file in 2 states: Massachusetts and Rhode Island.

CMS data shows 387 Medicare services from Dr. Cardarella across 4 procedure codes in 2024, for 179 Medicare patients. Medicare paid $35,345 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 179 Medicare patients who saw Dr. Cardarella in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cardarella's median patient age at 70, with 52% women.

In 2024, Dr. Cardarella wrote 87 Medicare Part D claims for 40 patients. 89% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $625 in total drug cost. In 2019, CMS named 309 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cardarella for performance year 2024, reported as part of a group. Dr. Cardarella accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Cardarella, published from 2012 to 2015. 2013 was the busiest year, with 4. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and ErbB Receptors. Dr. Cardarella's most frequent co-authors are Bruce Evan Johnson, MD, David M. Jackman, MD and Michael Seth Rabin, MD.

Dr. Cardarella graduated from McGill University, Faculty of Medicine in 2004.